--- title: "ILLUMINA, INC. (ILMN) stock: news and investor profile" url: "https://aibio.space/companies/illumina/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ILLUMINA, INC. (NASDAQ: ILMN), United States. Listing facts, related biotech companies and news on aibio.space." --- ILMN ILLUMINA, INC. NASDAQ · United States # ILLUMINA, INC. (ILMN) news ILLUMINA, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ILMN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest ILLUMINA, INC. news We have not published a story on ILLUMINA, INC. yet. When there is news, it will appear here. ## ILLUMINA, INC. at a glance - **Ticker**: ILMN - **Listing**: NASDAQ - **Country**: United States - **Cash, Sep 27, 2026**: $1.34 billion ### Related companies - [Cytek Biosciences](https://aibio.space/companies/cytek-biosciences/) NASDAQ: CTKB - [NEOGENOMICS INC](https://aibio.space/companies/neogenomics/) NASDAQ: NEO - [Baird Medical Investment Holdings](https://aibio.space/companies/baird-medical-investment/) NASDAQ: BDMD - [Premier Air Charter Holdings](https://aibio.space/companies/premier-air-charter/) OTC: PREM - [MiniMed Group](https://aibio.space/companies/minimed/) NASDAQ: MMED - [TransMedics Group](https://aibio.space/companies/transmedics/) NASDAQ: TMDX - [RadNet](https://aibio.space/companies/radnet/) NASDAQ: RDNT - [CBD Life Sciences](https://aibio.space/companies/cbd-life-sciences/) OTC: CBDL ### Also on NASDAQ - [Silence Therapeutics](https://aibio.space/companies/silence-therapeutics/) SLN - [Rocket One](https://aibio.space/companies/rocket-one/) RKTO - [Cryoport](https://aibio.space/companies/cryoport/) CYRX - [Alpha Tau Medical](https://aibio.space/companies/alpha-tau-medical/) DRTS - [MBX Biosciences](https://aibio.space/companies/mbx-biosciences/) MBX - [enVVeno Medical](https://aibio.space/companies/envveno-medical/) NVNO ## ILLUMINA, INC. annual financials | Line | FY ended Dec 28, 2025 | FY ended Dec 29, 2024 | |---|---|---| | Revenue | [$4.34 billion](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | [$4.37 billion](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | | Research and development | [$967.0 million](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | [$1.17 billion](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | | Net income (loss) | [$850.0 million](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | [-$1.22 billion](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | | Cash from operations | [$1.08 billion](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | [$837.0 million](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | | Cash and equivalents | [$1.42 billion](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000207/) | [$1.13 billion](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000207/) | | Short-term investments | [$215.0 million](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000207/) | [$93.0 million](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/) | Latest balance sheet, Sep 27, 2026 (10-Q): cash and equivalents $1.29 billion, plus short-term investments of $48.0 million, $1.34 billion in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about ILLUMINA, INC. What is the ticker symbol of ILLUMINA, INC.? ILLUMINA, INC. trades under the ticker ILMN on NASDAQ. Where is ILLUMINA, INC. listed? ILLUMINA, INC. is listed on NASDAQ. Which country or territory is ILLUMINA, INC. listed under? Our directory records ILLUMINA, INC. under United States. Does aibio.space cover ILLUMINA, INC.? aibio.space lists ILLUMINA, INC. among 2,820 public biotech companies and publishes its news here as stories appear. What was ILLUMINA, INC.'s revenue last year? $4.34 billion for the fiscal year ended Dec 28, 2025, as reported to the SEC. Is ILLUMINA, INC. profitable? ILLUMINA, INC. reported net income of $850.0 million for the fiscal year ended Dec 28, 2025, and generated $1.08 billion of cash from operations, per its annual report to the SEC. How much does ILLUMINA, INC. spend on research and development? $967.0 million in the fiscal year ended Dec 28, 2025, per its annual report. How much cash does ILLUMINA, INC. have? $1.34 billion in cash and short-term investments at Sep 27, 2026, per its 10-Q. ## Investor discussion: ILLUMINA, INC. Members talk about ILLUMINA, INC. (ILMN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at ILLUMINA, INC., newest first. Each line links the filing it comes from. 1. 2026-08-07 Legal Disclosed a shareholder lawsuit, subpoena or other legal matter. SEC Form 8-K (Items 8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1110803/000111080326000168/ex991notice8726.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ILMN on TradingView](https://www.tradingview.com/symbols/NASDAQ-ILMN/). ## Listing details ILLUMINA, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ILMN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ILLUMINA, INC. - **Ticker**: ILMN - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/illumina/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ILLUMINA, INC. (ILMN) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/illumina/